Concepedia

The two faces of L-DOPA: benefits and adverse side effects in the treatment of Encephalitis lethargica, Parkinson’s disease, multiple sclerosis and amyotrophic lateral sclerosis

Harold D. Foster, A. Hoffer

Medical Hypotheses · 2003 · 32 citations · 25 references

Concepts

MedicineNeurologyPharmacologyNeurodegenerationNeuropharmacologyPsychopharmacologyAmyotrophic Lateral SclerosisDopaminergic PharmacologyMultiple SclerosisNeurodegenerative DiseasesParkinson DiseaseParkinsonian DisordersAmyotrophic Lateral Sclerosis PathologyDopamine-related Movement DisordersDopaminergic Therapy ManagementMedication Adverse EffectsParkinson's Disease PharmacotherapyParkinson’s Disease PharmacotherapyParkinson’s Disease Treatment

References

25

Aromatic Amino Acids and Modification of Parkinsonism

George C. Cotzias, Melvin H. Van Woert, Lewis M. Schiffer · New England Journal of Medicine · 1967 · 1.5K citations

Life Sciences, Neurobiology, Neuroscience +17

Oxidative Pathways for Catecholamines in the Genesis of Neuromelanin and Cytotoxic Quinones

Doyle G. Graham · Molecular Pharmacology · 1978 · 1.1K citations

Life Sciences, Biochemistry, Neurobiology +10

Effects of Coenzyme Q10 in Early Parkinson Disease

Clifford W. Shults · Archives of Neurology · 2002 · 977 citations

Medicine, Pharmacology, Pharmacotherapy +17

Autoxidation versus Covalent Binding of Quinones as the Mechanism of Toxicity of Dopamine, 6-Hydroxydopamine, and Related Compounds toward C1300 Neuroblastoma Cells in Vitro

Doyle G. Graham, S M Tiffany, William R. Bell et al. · Molecular Pharmacology · 1978 · 956 citations

Life Sciences, Biochemistry, Toxicology +13

Glutathione peroxidase, glial cells and Parkinson's disease

Philippe Damier, Étienne C. Hirsch, P. Zhang et al. · Neuroscience · 1993 · 462 citations

Life Sciences, Neurobiology, Neuroscience +14